Ascentage Pharma Group International (AAPG)

AAPG Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-	-395.26	-932.86	-887.17	-836.1	-675.45
Depreciation & Amortization	-	93.17	93.2	62.92	28.33	27.42
Stock-Based Compensation	-	20.92	31.5	22.11	46.97	74.03
Other Adjustments	-	58.84	91.23	43.82	-33.53	11.78
Change in Receivables	-	62.75	-91.54	-0.39	-53.97	-
Changes in Inventories	-	9.57	-6.72	-5.52	-3.93	-
Changes in Accounts Payable	-	19.52	-23.11	24.7	47.5	10.28
Changes in Accrued Expenses	-	78.51	48.57	57.45	17.87	-26.02
Changes in Unearned Revenue	-	4.09	82.98	-24.66	227.39	5.11
Changes in Other Operating Activities	-	-63.47	-19.33	52.83	-45.21	-37.1
Operating Cash Flow	-189.09	-111.36	-726.08	-653.92	-600.83	-609.96
Capital Expenditures	-27.8	-24.29	-46.11	-203.29	-435.42	-249.92
Sale of Property, Plant & Equipment	-	-	0.01	2.35	0.34	-
Purchases of Intangible Assets	-	-	-10.74	-33.68	-1.21	-1.56
Purchases of Investments	-44	-16	-	-	-1,800	-2,170
Proceeds from Sale of Investments	-	-	-	-	1,790	2,175
Payments for Business Acquisitions	-43.34	-9.52	-20	-20	-20	-
Other Investing Activities	-597.14	-312.23	98.75	-130	-	139.52
Investing Cash Flow	-935.28	-362.04	21.92	-384.61	-466.52	-107.37
Long-Term Debt Issued	820.58	535.92	953.5	763.62	599.74	527.81
Long-Term Debt Repaid	-813.52	-672.85	-956.09	-54.5	-51.15	-95
Net Long-Term Debt Issued (Repaid)	7.06	-136.93	-2.59	709.11	548.59	432.81
Issuance of Common Stock	950.2	533.95	470.09	0.02	1,301	634.22
Repurchase of Common Stock	-9.2	-	-5.92	-26.78	-25.87	-
Net Common Stock Issued (Repurchased)	940.99	533.95	464.17	-26.76	1,275	634.22
Other Financing Activities	-81.4	-82.25	-92.82	-63.09	-41.97	-27.02
Financing Cash Flow	868.61	314.77	368.75	619.27	1,781	1,040
Effect of Exchange Rate Changes on Cash and Cash Equivalents	6.92	13.68	27.81	58.01	-23.28	-41.69
Net Cash Flow	-255.75	-158.63	-335.4	-419.26	710.19	322.68
Free Cash Flow	-216.89	-135.65	-772.19	-857.2	-1,036	-859.88
FCF Margin	-55.53%	-13.83%	-347.86%	-408.75%	-3712.82%	-6906.64%
Free Cash Flow Per Share	-2.67	-1.80	-10.94	-13.00	-16.28	-15.93
Levered Free Cash Flow	-1,180	-425.26	-798.75	-209.38	-397.31	-515.03
Unlevered Free Cash Flow	-1,205	-281.01	-767.72	-932.34	-1,088	-986.97

Updated Sep 19, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q